What is the highest clinical development phase of ablysinol in the us and which indications contribute to this phase?

What phase is ablysinol in (highest clinical development phase in the U.S.)?

Ablysinol has reached Phase 2 clinical development in the U.S., meaning its most advanced U.S. clinical studies are being conducted to evaluate efficacy and safety in patients. [1]

Which indications are driving ablysinol’s Phase 2 development?

The Phase 2 U.S. development is supported by at least two indication areas:
- Cancer
- HIV/AIDS [1]

Are there any other indications besides those contributing to Phase 2?

Based on the available development-stage information, the indications explicitly tied to the company’s advanced (Phase 2) U.S. clinical development are cancer and HIV/AIDS. [1]

Sources
[1] https://www.drugpatentwatch.com/p/ablysinol